Braidio integrates with BlueSemi, to improve remote patient monitoring and telehealth

      Braidio’s My Health Concierge™ platform, the single point platform that threads information, people, and business tools, is partnering with BlueSemia's handheld gadget Eyva, which measures 6 key vitals to connect people worldwide directly to their health and to encourage positive behavioural change. My Health Concierge™ contains embedded healthcare workflows, including triggered events and write-back capabilities. With BlueSemi's Eyva, tracking critical vitals including blood glucose, HbA1c, ECG, blood pressure, oxygen and heart rate, the two companies can ensure that the healthcare providers have the latest data of the people they care for. The sensors in Eyva, respond to the user's touch to measure the vitals and provides the results in 60 seconds. The tests and vitals results can be directly sent from Eyva via the personalized app, which also helps to manage care and appointments. With this, the healthcare providers can provide quality remote health care for a large group of people with limited time, effort or resources.

Read More

Eversense E3, 180-day implantable CGM, approved by FDA

      The Food and Drug Administration (FDA) approved Sensonics 180-day implantable continuous glucose monitor (CGM) – The Eversense E3, for people with diabetes who are 18 years and older. The Eversense E3 is an implantable CGM that can be used for 180 days before replacement. The sensor is inserted under the skin of the upper arm (and removed) every six months by a trained healthcare provider. The device has a rechargeable transmitter that sends glucose data via a bluetooth connection to a mobile device app. It is the only CGM that provides on-the-body vibrating alerts for highs and lows.

Read More